Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ileana Murazzi"'
Autor:
Ashley M. Fuller, Ann DeVine, Ileana Murazzi, Nicola J. Mason, Kristy Weber, T. S. Karin Eisinger-Mathason
Publikováno v:
Cellular Oncology. 45:1277-1295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e917853fc3508c58577a74c348eb2052
https://doi.org/10.1007/s13402-022-00717-1
https://doi.org/10.1007/s13402-022-00717-1
Autor:
Ashley M, Fuller, Ann, DeVine, Ileana, Murazzi, Nicola J, Mason, Kristy, Weber, T S Karin, Eisinger-Mathason
Publikováno v:
Cellular oncology (Dordrecht). 45(6)
Undifferentiated pleomorphic sarcoma (UPS), an aggressive subtype of soft-tissue sarcoma (STS), is exceedingly rare in humans and lacks effective, well-tolerated therapies. In contrast, STS are relatively common in canine companion animals. Thus, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08fe7b289e8e87ca50f9668291a242f1
https://pubmed.ncbi.nlm.nih.gov/36181640
https://pubmed.ncbi.nlm.nih.gov/36181640
Autor:
Hawley C. Pruitt, Ashley M. Fuller, Hoogeun Song, Ying Liu, Ann DeVine, Rohan Katti, Samir Devalaraja, Gabrielle E. Ciotti, Michael Gonzalez, Erik F. Williams, Ileana Murazzi, Nicolas Skuli, Hakon Hakonarson, Kristy Weber, Malay Haldar, Joseph A. Fraietta, Sharon Gerecht, T. S. Karin Eisinger-Mathason
CD8+ T cell dysfunction is a critical barrier to anti-tumor immunity, but molecular mechanisms underlying the regulation of T cell dysfunction in solid tumors are diverse and complex. Extracellular matrix (ECM) composition facilitates solid tumor pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7429eee4f90250c96407dbf751f331f
https://doi.org/10.1101/2022.03.31.486627
https://doi.org/10.1101/2022.03.31.486627
Autor:
Ashley M. Fuller, Ann DeVine, Ileana Murazzi, Nicola J. Mason, Kristy Weber, T. S. Karin Eisinger-Mathason
Undifferentiated pleomorphic sarcoma (UPS), an aggressive subtype of soft-tissue sarcoma (STS), is exceedingly rare in humans and lacks effective, well-tolerated therapies. In contrast, STS are relatively common in canine companion animals; thus, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4f6d3baec103d40c074f3482687bf3
https://doi.org/10.1101/2021.12.22.473852
https://doi.org/10.1101/2021.12.22.473852
Autor:
Ashley M. Fuller, Hawley C. Pruitt, Hoogeun Song, Ying Liu, Ann Devine, Rohan S. Katti, Samir Devalaraja, Gabrielle E. Ciotti, Michael Gonzalez, Erik F. Williams, Ileana Murazzi, Nicolas Skuli, Hakon Hakonarson, Kristy Weber, Malay Haldar, Joseph A. Fraietta, Sharon Gerecht, T. S. Karin Eisinger-Mathason
Publikováno v:
Clinical Cancer Research. 28:PR001-PR001
CD8+ T cell dysfunction, characterized by reduced effector function, impaired proliferation, and inhibitory receptor upregulation, is a fundamental barrier to anti-tumor immunity. However, molecular mechanisms underlying the regulation of CD8+ T cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7df6161bac8036aa0ae45d350c2b93b8
https://doi.org/10.1158/1557-3265.sarcomas22-pr001
https://doi.org/10.1158/1557-3265.sarcomas22-pr001
Publikováno v:
Clinical Cancer Research. 28:B017-B017
Metastasis is the leading cause of cancer-related deaths. However, the mechanisms behind the metastatic cascade remain poorly understood. Tumor’s metastatic potential is strongly influenced by microenvironmental cues such as low oxygen (hypoxia). O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af545f6b800fa4d439ae77d20d7a5c72
https://doi.org/10.1158/1557-3265.sarcomas22-b017
https://doi.org/10.1158/1557-3265.sarcomas22-b017
Publikováno v:
Clinical Cancer Research. 28:IA024-IA024
Only a small percentage of disseminating tumor cells are capable of forming lethal metastatic foci. Though advances in sequencing and genomics have dramatically enhanced our understanding of primary tumor biology and novel target identification, thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3964a5b8acaa423e28fa1d5013e6027f
https://doi.org/10.1158/1557-3265.sarcomas22-ia024
https://doi.org/10.1158/1557-3265.sarcomas22-ia024